Since, compared to normal tissues, tumor tissues are enriched for cells in S/G2/M stage of the cell cycle (Fig. 3F), these data strongly suggest that the G1-specific peak levels of EEF1A1 mRNA predominantly account for our observation that EEF1A1 mRNA levels are reduced in breast carcinoma. The gene discussed is EEF1A1; the disease is neoplasm.